SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : BJCT-BIOJECT-needle less injection product -- Ignore unavailable to you. Want to Upgrade?


To: James Strauss who wrote (193)6/4/1998 11:24:00 PM
From: GREG FINLEY  Read Replies (2) | Respond to of 534
 
Jim or Marc;
Or anyone! Care to guess what a possible takeover price might be.
I hope, of course, that the alliances produce the required revenues to turn a profit by last quarter this year...one quarter in the black for BJCT, and we see some serious gains. A takeover would greatly reduce the potential for enormous profit...I am not greedy though...I want to see all of us rewarded handsomely for our faith and our patience!
Whatever your thoughts,...!



To: James Strauss who wrote (193)6/6/1998 1:26:00 AM
From: LTK007  Read Replies (1) | Respond to of 534
 
Jim,I am having problems finding Hoffman-Larouche,is it a private company.I confess I am totally ignorant as to who they are--am continuing to follow BJCT as I still have cash looking for places to
go.Max Off topic--was amazed to see an analyst tonite on WSW (Stovall)
recommend Greyhound Bus as a buy--hmmm